Ocular Therapeutix, Inc.
OCUL
$10.97
-$0.08-0.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -64.65M | -69.42M | -67.81M | -64.05M | -48.39M |
| Total Depreciation and Amortization | 1.25M | 1.07M | 1.03M | 981.00K | 951.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.26M | 13.90M | 11.00M | 12.87M | 7.15M |
| Change in Net Operating Assets | -2.10M | 3.73M | 552.00K | 5.53M | 858.00K |
| Cash from Operations | -54.25M | -50.73M | -55.24M | -44.67M | -39.43M |
| Capital Expenditure | -2.84M | -5.99M | -1.25M | -1.93M | -202.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 130.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.84M | -5.99M | -1.12M | -1.93M | -202.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 449.38M | 10.36M | 97.81M | 4.18M | 4.51M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 449.38M | 10.36M | 97.81M | 4.18M | 4.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 392.29M | -46.36M | 41.45M | -42.42M | -35.12M |